home

INCY.US | summary | financial summary | prediction chart | global stock news | news graph | compare | components | pairs | earnings
symbollastchange%chngnamemcapsectorwiki
INCY
US
Incyte Corporation 15.238B Healthcare wiki y

Market global news for INCY (US) Incyte

Global news - US chevrons indicate local prediction, arrows show global predictions
Today
Incyte scoops up preclinical biotech to widen footprint in vitiligo
fiercebiotech - 4h ago - INCY - link story
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody
yahoo - 17:15 Mon - INCY - link story
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody
businesswire - 16:00 Mon - INCY - link story
previous days
Taiho Oncology, Inc.: FDA Approves Taiho's LYTGOBI (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
finanznachrichten de - 22:45 Fri 30 - INCY - link story
FDA Approves Taiho's LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
streetinsider - 21:30 Fri 30 - INCY - link story
Incyte abandons solid tumour programme for Jakafi
pmlive - 19:30 Thu 22 - INCY - link story
Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers (Ruxolitinib (Jakafi) helps)
freerepublic - 03:00 Tue 20 - INCY - link story
FDA Approves Incyte's Pemazyre as the First and Only Targeted Treatment for Rare Blood Cancer
globalgenes org - 17:15 Mon 29 - INCY - link story
Incyte secures second approval for targeted cancer drug
biopharmadive - 16:45 Mon 29 - INCY - link story
FDA OKs First Targeted Agent, Pemigatinib, for Rare Blood Cancer
medscape - 23:30 Fri 26 - INCY - link story
FDA approves pemigatinib for myeloid/lymphoid neoplasms with FGFR1 rearrangement
healio - 23:15 Fri 26 - INCY - link story
Incyte Gets FDA Approval for Rare-Blood-Cancer Treatment
marketwatch - 15:15 Fri 26 - INCY - link story
Incyte: FDA Oks Pemazyre For Treatment Of Myeloid/lymphoid Neoplasms With FGFR1 Rearrangement
finanznachrichten de - 15:00 Fri 26 - INCY - link story
Incyte (INCY) Announces FDA Approval of Pemazyre
streetinsider - 15:00 Fri 26 - INCY - link story
Incyte Announces FDA Approval of Pemazyre (pemigatinib) as the First and Only Targeted Treatment for Myeloid/Lymphoid Neoplasms (MLNs) with FGFR1 Rearrangement
finanznachrichten de - 14:30 Fri 26 - INCY - link story